Twitter | Pretraživanje | |
Pretraživanje Osvježi
I Am Biotech 6 h
Coming soon at : Speaker Dr. Benjamin Cowen, of ImmunoMet, a clinical-stage company developing anti-tumor and immune-metabolism therapies. Here's an early look:
Reply Retweet Označi sa "sviđa mi se"
Richard Andersen 6 h
Learn the 10 most common false assumptions made during biopharma partnering deals from expert business development consultant, Linda Pullan, PhD of . Read the blog >> |
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 6 h
Make sure to catch fireside chats from Barbara Dalton of and other key biotech and pharma leaders, including , ; Ted W. Love, ; Michael M. Morrissey, and Carol Lynch, at ! View the complete program⬇️
Reply Retweet Označi sa "sviđa mi se"
Business Wire 7 h
ROTH Capital Partners to Sponsor & Speak at BIO CEO Conference | Business Wire
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 9 h
What's next in fighting solid tumors? Dr. Benjamin Cowen, CEO of , a clinical stage biotech company developing anti-tumor and immune-metabolism therapies, will speak about that and his impressive experience in biotech at .
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 12 h
See who you can meet at , the must-attend meeting for top investment firms in the region! More than 340 investors have already registered, including , and .
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 14 h
Thank you for providing scholarships to NYC’s innovative biotechs to attend and pitch investors. See you next week!
Reply Retweet Označi sa "sviđa mi se"
AiCure 17 h
We look forward to seeing you in next week! is a proud sponsor of the BIO CEO & Investor Conference Feb. 10-11
Reply Retweet Označi sa "sviđa mi se"
I Am Biotech 4. velj
Meet ImmunoMet’s Dr. Benjamin Cowen, Speaker at
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 4. velj
💡PANEL SPOTLIGHT💡 Catch the Market Performance and IPO Class of 2020 panel at and examine whether the overall market will experience a cooling off period in 2020 or if we are at the beginning of a long-term growth cycle. View the complete program⬇️
Reply Retweet Označi sa "sviđa mi se"
EpimAb Biotherapeutics 4. velj
Our COO/CBO Stephan Lensky is presenting at the BIO CEO & Investor Conference taking place February 10-11 in . Schedule a meeting with us to learn more.
Reply Retweet Označi sa "sviđa mi se"
Venture Valuation 4. velj
Last chance to register to organized by next week!
Reply Retweet Označi sa "sviđa mi se"
Boundless Bio 4. velj
We’re busy this month! Don’t miss presentations from our CEO, , at ’s and our CTO, Jason Christiansen, at ’ Biomarker and Companion Diagnostics Conference. Details here:
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 4. velj
The Syneos One team at Syneos Health is dedicated to delivering fully integrated solutions focused on cost, speed, and risk mitigation to increase an asset’s NPV. Schedule a meeting with us at to learn more.
Reply Retweet Označi sa "sviđa mi se"
Summit Therapeutics 4. velj
We're presenting at on Monday at 2:15pm EST. Listen to the webcast via the link in our investors section of our website.
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 2. velj
Syneos Health provides capital solutions for biotechs by connecting innovators with the ‘right’ capital sources, and works with both to maximize ROI in a strategic ‘end to end’ model. Schedule a meeting with the Syneos team at to learn more.
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 31. sij
The Syneos One team at Syneos Health optimizes product development, thus creating the potential for cost efficiencies, increased speed to market, and de-risking of investment dollars. Meet us at and learn more.
Reply Retweet Označi sa "sviđa mi se"
BIO 1x1 Partnering 31. sij
Download BIO’s first annual report: Measuring Diversity in the Biotech Industry: Building an Inclusive Workforce. Visit for your copy, and attend "Industry Approaches for Hiring and Developing an Inclusive Workforce" at to learn more!
Reply Retweet Označi sa "sviđa mi se"